Back
Day Range
$116.80
$123.94
52-Week Range
$18.23
$151.18
Volume
259,922
50D / 200D Avg
$103.28
/
$71.39
Prev Close
$116.23
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -81.7 | 0.2 |
| P/B | 22.8 | 3.0 |
| ROE % | -59.4 | 3.6 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$203.92
+69.4%
Low: $143.00
High: $255.00
Forward EPS
-$3.88
Est. Revenue
26,667.0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$7.28
$7.28 – $7.28
|
307.96M | 4 |
| FY2028 |
-$0.74
-$7.04 – $11.06
|
126.32M | 10 |
| FY2027 |
-$4.99
-$9.33 – -$2.66
|
24.88M | 11 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-11 | -$0.85 | -$1.03 | -21.2% |
| 2025-08-14 | -$0.78 | -$0.86 | -10.3% |
| 2025-05-15 | -$3.40 | -$0.74 | +78.2% |
| 2025-03-31 | -$0.39 | $4.00 | +1125.6% |
| 2024-11-13 | -$0.55 | -$2.19 | -301.8% |
| 2024-08-14 | -$2.40 | -$2.76 | -15.0% |
| 2024-05-16 | -$4.80 | -$2.00 | +58.3% |
| 2024-03-30 | -$9.60 | -$3.71 | +61.4% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Earnings declined -193.27% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -10.84M
PEG of 0.01 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-193.27%
FCF Growth (3Y)N/A
Quality
Return on Equity
-59.37%
ROIC-16.89%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio7.33
Interest Coverage-3.27
Valuation
P/E Ratio
-81.74
Forward P/EN/A
P/B Ratio22.76
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -193.27% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -17.43M |
| ROE | -59.37% | ROA | -19.76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -10.84M |
| ROIC | -16.89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 7.33 |
| Interest Coverage | -3.27 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -81.74 | Forward P/E | N/A |
| P/B Ratio | 22.76 | P/S Ratio | N/A |
| PEG Ratio | 0.01 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 251548.13 |
| Forward P/S | 53440.89 | Fwd Earnings Yield | N/A |
| FCF Yield | -0.76% | ||
| Market Cap | 1.43B | Enterprise Value | 1.34B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 25.90M | 31.42M |
| Net Income | -17.43M | 18.69M | -33.28M | -45.74M |
| EPS (Diluted) | -7.83 | 14.74 | -29.61 | -56.69 |
| Gross Profit | 0.0 | 0.0 | 23.12M | 29.05M |
| Operating Income | -14.10M | -11.87M | -43.47M | -51.83M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 88.23M | 7.55M | 16.52M | 153.56M | 105.01M |
| Total Liabilities | 25.63M | 11.43M | 39.70M | 102.81M | 73.98M |
| Shareholders' Equity | 62.61M | -3.88M | -23.17M | 50.76M | 31.03M |
| Total Debt | 0.0 | 0.0 | 0.0 | 14.89M | 16.96M |
| Cash & Equivalents | 83.60M | 7.35M | 16.05M | 117.76M | 70.44M |
| Current Assets | 88.23M | 7.55M | 16.52M | 127.63M | 75.72M |
| Current Liabilities | 12.04M | 2.36M | 5.78M | 50.56M | 22.15M |